1928 Diagnostics
Fighting antibiotic resistance with DNA analytics
1928 Diagnostics is active in the biotechnology, health diagnostics, medical, software space based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2014.
1928 Diagnostics is positioned in biotechnology, health diagnostics, medical, software, a segment that rewards a clear, focused offering.
European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) is where the company is located.
The company is listed at the Series_Unknown stage of development.
Its team size is recorded as c_00011_00050 employees.
It has disclosed roughly $8.6M in funding.
| Sector | Biotechnology, Health Diagnostics, Medical, Software |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2014 |
| Employees | c_00011_00050 |
| Stage | series_unknown |
| Total funding | $8,557,151 |
Website: www.1928diagnostics.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account